Bumadizone
Bumadizone, or bumazidone, is a nonsteroidal anti-inflammatory drug (NSAID).
![]()  | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names | 
| ATC code | |
| Identifiers | |
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.020.646 | 
| Chemical and physical data | |
| Formula | C19H22N2O3 | 
| Molar mass | 326.396 g·mol−1 | 
| 3D model (JSmol) | |
  | |
  | |
| (verify) | |
References
    
| pyrazolones / pyrazolidines  | |
|---|---|
| salicylates | |
| acetic acid derivatives and related substances  | |
| oxicams | 
  | 
| propionic acid derivatives (profens)  | 
  | 
| n-arylanthranilic acids (fenamates)  | |
| COX-2 inhibitors (coxibs)  | |
| other | |
| NSAID combinations  | |
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use.  | |
  | |
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
